Your browser doesn't support javascript.
loading
IL-25 enhances TH17 cell-mediated contact dermatitis by promoting IL-1ß production by dermal dendritic cells.
Suto, Hajime; Nambu, Aya; Morita, Hideaki; Yamaguchi, Sachiko; Numata, Takafumi; Yoshizaki, Takamichi; Shimura, Eri; Arae, Ken; Asada, Yousuke; Motomura, Kenichiro; Kaneko, Mari; Abe, Takaya; Matsuda, Akira; Iwakura, Yoichiro; Okumura, Ko; Saito, Hirohisa; Matsumoto, Kenji; Sudo, Katsuko; Nakae, Susumu.
Affiliation
  • Suto H; Atopy Research Center, Juntendo University, Tokyo, Japan.
  • Nambu A; Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Morita H; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Yamaguchi S; Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Numata T; Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yoshizaki T; Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Shimura E; Atopy Research Center, Juntendo University, Tokyo, Japan; Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Arae K; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Department of Immunology, Faculty of Health Science, Kyorin University, Tokyo, Japan.
  • Asada Y; Department of Ophthalmology, Juntendo University, Tokyo, Japan.
  • Motomura K; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Kaneko M; Animal Resource Development Unit, RIKEN Center for Life Science Technologies, Kobe, Japan; Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, Japan.
  • Abe T; Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, Japan.
  • Matsuda A; Department of Ophthalmology, Juntendo University, Tokyo, Japan.
  • Iwakura Y; Center for Experimental Animal Models, Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Okumura K; Atopy Research Center, Juntendo University, Tokyo, Japan.
  • Saito H; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Matsumoto K; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Sudo K; Animal Research Center, Tokyo Medical University, Tokyo, Japan.
  • Nakae S; Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Saitama, Japan. Electronic address: snakae@ims.u-tokyo.
J Allergy Clin Immunol ; 142(5): 1500-1509.e10, 2018 11.
Article in En | MEDLINE | ID: mdl-29522843
ABSTRACT

BACKGROUND:

In addition to thymic stromal lymphopoietin and IL-33, IL-25 is known to induce TH2 cytokine production by various cell types, including TH2 cells, TH9 cells, invariant natural killer T cells, and group 2 innate lymphoid cells, involved in TH2-type immune responses. Because both TH2-type and TH17-type cells/cytokines are crucial for contact hypersensitivity (CHS), IL-25 can contribute to this by enhancing TH2-type immune responses. However, the precise role of IL-25 in the pathogenesis of fluorescein isothiocyanate-induced CHS is poorly understood.

OBJECTIVE:

We investigated the contribution of IL-25 to CHS using Il25-/- mice.

METHODS:

CHS was evaluated by means of measurement of ear skin thickness in mice after fluorescein isothiocyanate painting. Skin dendritic cell (DC) migration, hapten-specific TH cell differentiation, and detection of IL-1ß-producing cells were determined by using flow cytometry, ELISA, and immunohistochemistry, respectively.

RESULTS:

In contrast to thymic stromal lymphopoietin, we found that IL-25 was not essential for skin DC migration or hapten-specific TH cell differentiation in the sensitization phase of CHS. Unexpectedly, mast cell- and non-immune cell-derived IL-25 was important for hapten-specific TH17 cell-mediated rather than TH2 cell-mediated inflammation in the elicitation phase of CHS by enhancing TH17-related, but not TH2-related, cytokines in the skin. In particular, IL-1ß produced by dermal DCs in response to IL-25 was crucial for hapten-specific TH17 cell activation, contributing to induction of local inflammation in the elicitation phase of CHS.

CONCLUSION:

Our results identify a novel IL-25 inflammatory pathway involved in induction of TH17 cell-mediated, but not TH2 cell-mediated, CHS. IL-25 neutralization can be a potential approach for treatment of CHS.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytokines / Dermatitis, Allergic Contact / Th17 Cells Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Allergy Clin Immunol Year: 2018 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytokines / Dermatitis, Allergic Contact / Th17 Cells Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Allergy Clin Immunol Year: 2018 Type: Article Affiliation country: Japan